logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Moulton, Jonathan Paul
    Born in October 1950
    Individual (47 offsprings)
    Officer
    icon of calendar 2016-09-06 ~ now
    OF - Director → CIF 0
  • 2
    Doherty, Christopher
    Born in March 1961
    Individual (2 offsprings)
    Officer
    icon of calendar 2016-09-06 ~ now
    OF - Director → CIF 0
  • 3
    Jackson, Peter, Dr
    Born in February 1963
    Individual (5 offsprings)
    Officer
    icon of calendar 2016-02-05 ~ now
    OF - Director → CIF 0
  • 4
    Leonard, Colm, Professor
    Born in July 1967
    Individual (2 offsprings)
    Officer
    icon of calendar 2023-02-01 ~ now
    OF - Director → CIF 0
  • 5
    INFEX THERAPEUTICS HOLDINGS LIMITED - 2022-05-05
    icon of addressShoosmiths Llp, 100 Avebury Boulevard, Milton Keynes, England
    Active Corporate (4 parents, 1 offspring)
    Equity (Company account)
    2,617,652 GBP2024-07-31
    Person with significant control
    icon of calendar 2022-04-06 ~ now
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
Ceased 9
  • 1
    Mackay, Kathleen Phillippa, Dr
    Director born in April 1979
    Individual (7 offsprings)
    Officer
    icon of calendar 2019-10-18 ~ 2021-08-11
    OF - Director → CIF 0
  • 2
    Yadi, Hakim Adam, Dr
    Director born in March 1984
    Individual (3 offsprings)
    Officer
    icon of calendar 2016-09-06 ~ 2019-03-29
    OF - Director → CIF 0
  • 3
    Stasiak, Pauline Christine, Dr
    Director born in February 1963
    Individual (1 offspring)
    Officer
    icon of calendar 2019-03-21 ~ 2021-05-18
    OF - Director → CIF 0
  • 4
    Thorn, Simon William
    Individual (4 offsprings)
    Officer
    icon of calendar 2016-02-05 ~ 2017-12-12
    OF - Secretary → CIF 0
  • 5
    Payne, Lloyd James, Dr
    Director born in August 1971
    Individual (3 offsprings)
    Officer
    icon of calendar 2016-09-06 ~ 2017-04-11
    OF - Director → CIF 0
  • 6
    Flinn, Anthony, Dr
    Company Director born in October 1958
    Individual (8 offsprings)
    Officer
    icon of calendar 2017-07-19 ~ 2022-05-12
    OF - Director → CIF 0
  • 7
    icon of addressTrafalgar Court, 2nd Floor, East Wing, Admiral Park, St Peter Port, Guernsey, Guernsey
    Corporate (5 offsprings)
    Person with significant control
    2017-07-19 ~ 2017-07-19
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 8
    icon of address11, Burrough Court, Burrough On The Hill, Melton Mowbray, England
    Active Corporate (2 parents, 3 offsprings)
    Person with significant control
    2017-07-19 ~ 2022-04-06
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 9
    BRUNTWOOD CORRIDOR COMPANY LIMITED - 2014-03-21
    icon of addressUnion, Albert Square, Manchester, England
    Active Corporate (8 parents, 14 offsprings)
    Person with significant control
    2017-07-19 ~ 2019-03-21
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
parent relation
Company in focus

INFEX THERAPEUTICS LIMITED

Previous name
AMR CENTRE LIMITED - 2020-09-22
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Property, Plant & Equipment
2,475 GBP2024-07-31
15,465 GBP2023-07-31
Debtors
908,564 GBP2024-07-31
706,365 GBP2023-07-31
Cash at bank and in hand
120,655 GBP2024-07-31
262,388 GBP2023-07-31
Current Assets
1,029,219 GBP2024-07-31
968,753 GBP2023-07-31
Creditors
Current
11,080,802 GBP2024-07-31
1,172,477 GBP2023-07-31
Net Current Assets/Liabilities
-10,051,583 GBP2024-07-31
-203,724 GBP2023-07-31
Total Assets Less Current Liabilities
-10,049,108 GBP2024-07-31
-188,259 GBP2023-07-31
Creditors
Non-current
5,957,479 GBP2023-07-31
Net Assets/Liabilities
-10,049,108 GBP2024-07-31
-6,145,738 GBP2023-07-31
Equity
Called up share capital
91,543 GBP2024-07-31
92,043 GBP2023-07-31
Share premium
6,098,910 GBP2024-07-31
6,098,910 GBP2023-07-31
Retained earnings (accumulated losses)
-16,239,561 GBP2024-07-31
-12,361,191 GBP2023-07-31
Equity
-10,049,108 GBP2024-07-31
-6,145,738 GBP2023-07-31
Average Number of Employees
222023-08-01 ~ 2024-07-31
222022-08-01 ~ 2023-07-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
141,923 GBP2023-07-31
Furniture and fittings
5,243 GBP2023-07-31
Computers
5,990 GBP2023-07-31
Property, Plant & Equipment - Gross Cost
153,156 GBP2023-07-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
139,448 GBP2024-07-31
126,458 GBP2023-07-31
Furniture and fittings
5,243 GBP2024-07-31
5,243 GBP2023-07-31
Computers
5,990 GBP2024-07-31
5,990 GBP2023-07-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
150,681 GBP2024-07-31
137,691 GBP2023-07-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
12,990 GBP2023-08-01 ~ 2024-07-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
12,990 GBP2023-08-01 ~ 2024-07-31
Property, Plant & Equipment
Plant and equipment
2,475 GBP2024-07-31
15,465 GBP2023-07-31
Other Debtors
Current
132,647 GBP2023-07-31
Amount of corporation tax that is recoverable
Current
812,172 GBP2024-07-31
440,865 GBP2023-07-31
Amount of value-added tax that is recoverable
Current
22,285 GBP2024-07-31
69,576 GBP2023-07-31
Prepayments
Current
74,107 GBP2024-07-31
63,277 GBP2023-07-31
Debtors
Current, Amounts falling due within one year
908,564 GBP2024-07-31
706,365 GBP2023-07-31
Trade Creditors/Trade Payables
Current
299,304 GBP2024-07-31
747,982 GBP2023-07-31
Amounts owed to group undertakings
Current
10,369,055 GBP2024-07-31
Other Taxation & Social Security Payable
Current
42,198 GBP2024-07-31
36,424 GBP2023-07-31
Other Creditors
Current
218,750 GBP2024-07-31
218,750 GBP2023-07-31
Accrued Liabilities
Current
151,495 GBP2024-07-31
169,321 GBP2023-07-31
Amounts owed to group undertakings
Non-current
5,957,479 GBP2023-07-31
Profit/Loss
Retained earnings (accumulated losses)
-3,903,370 GBP2023-08-01 ~ 2024-07-31
Profit/Loss
-3,903,370 GBP2023-08-01 ~ 2024-07-31

  • INFEX THERAPEUTICS LIMITED
    Info
    AMR CENTRE LIMITED - 2020-09-22
    Registered number 09990238
    icon of addressMereside, Alderley Park, Macclesfield SK10 4TG
    PRIVATE LIMITED COMPANY incorporated on 2016-02-05 (9 years 10 months). The company status is Active.
    The last date of confirmation statement was made at 2025-01-30
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.